217 related articles for article (PubMed ID: 33794524)
1. Clinical Characteristics, Management, and Natural History of Chronic Inducible Urticaria in a Pediatric Cohort.
Miles LM; Gabrielli S; Le M; Netchiporouk E; Baum S; Greenberger S; Ensina LF; Jafarian F; Zhang X; Ben-Shoshan M
Int Arch Allergy Immunol; 2021; 182(8):757-764. PubMed ID: 33794524
[TBL] [Abstract][Full Text] [Related]
2. Chronic urticaria phenotypes: clinical differences regarding triggers, activity, prognosis and therapeutic response.
Curto-Barredo L; Pujol RM; Roura-Vives G; Gimenez-Arnau AM
Eur J Dermatol; 2019 Dec; 29(6):627-635. PubMed ID: 31903953
[TBL] [Abstract][Full Text] [Related]
3. Chronic inducible urticaria: classification and prominent features of physical and non-physical types.
Pozderac I; Lugović-Mihić L; Artuković M; Stipić-Marković A; Kuna M; Ferček I
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Sep; 29(3):141-148. PubMed ID: 32975301
[TBL] [Abstract][Full Text] [Related]
4. Chronic Inducible Urticaria.
Ritzel D; Altrichter S
Immunol Allergy Clin North Am; 2024 Aug; 44(3):439-452. PubMed ID: 38937008
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Comorbidities, Natural History, and Predictors of Early Resolution in a Cohort of Children With Chronic Urticaria.
Netchiporouk E; Sasseville D; Moreau L; Habel Y; Rahme E; Ben-Shoshan M
JAMA Dermatol; 2017 Dec; 153(12):1236-1242. PubMed ID: 28973060
[TBL] [Abstract][Full Text] [Related]
6. The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update.
Maurer M; Zuberbier T; Metz M
Handb Exp Pharmacol; 2022; 268():117-133. PubMed ID: 34247278
[TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of chronic inducible urticaria in 423 patients: Clinical and laboratory features and comorbid conditions.
Ornek Ozdemir S; Kuteyla Can P; Degirmentepe EN; Cure K; Singer R; Kocaturk E
J Eur Acad Dermatol Venereol; 2024 Mar; 38(3):513-520. PubMed ID: 37991240
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience of a chronic urticaria referral university center.
Andrade Coelho Dias G; Cunha Coelho F; Filippo P; Lacerda Pedrazzi D; Nogueira Arraes AC; Perelló MI; Chigres Kuschnir F; Costa E
Eur Ann Allergy Clin Immunol; 2020 May; 52(3):112-120. PubMed ID: 31287262
[No Abstract] [Full Text] [Related]
9. Chronic inducible urticaria subtypes in children: Clinical features and prognosis.
Bal F; Kahveci M; Soyer O; Sekerel BE; Sahiner UM
Pediatr Allergy Immunol; 2021 Jan; 32(1):146-152. PubMed ID: 32741017
[TBL] [Abstract][Full Text] [Related]
10. Cold urticaria in a pediatric cohort: Clinical characteristics, management, and natural history.
Prosty C; Gabrielli S; Mule P; Le Gallee M; Miles LM; Le M; Zhang X; Ensina LF; Netchiporouk E; Ben-Shoshan M
Pediatr Allergy Immunol; 2022 Mar; 33(3):e13751. PubMed ID: 35338743
[TBL] [Abstract][Full Text] [Related]
11. Pediatric chronic urticaria: Clinical and laboratory characteristics and factors linked to remission.
Sandoval-Ruballos M; Domínguez O; Ortiz de Landazuri I; Gereda D; Espinoza Cisneros M; Quesada Sequeira F; Ramos Rodríguez SM; Machinena A; Piquer M; Folqué MDM; Lozano J; Jiménez-Feijoo R; Pascal M; Alvaro-Lozano M
Pediatr Allergy Immunol; 2023 Mar; 34(3):e13929. PubMed ID: 36974641
[TBL] [Abstract][Full Text] [Related]
12. Chronic inducible urticaria: A systematic review of treatment options.
Dressler C; Werner RN; Eisert L; Zuberbier T; Nast A; Maurer M
J Allergy Clin Immunol; 2018 May; 141(5):1726-1734. PubMed ID: 29438771
[TBL] [Abstract][Full Text] [Related]
13. IgE receptor responsiveness of basophils in chronic inducible urticaria.
Mizuno M; Oda Y; Imamura S; Washio K; Fukumoto T; Fukunaga A
Front Immunol; 2022; 13():995596. PubMed ID: 36211415
[TBL] [Abstract][Full Text] [Related]
14. Unveiling Treatment Response Predictors in Predominant Subtypes of Chronic Inducible Urticaria.
Ornek Ozdemir S; Can PK; Degirmentepe EN; Kızıltaç K; Singer R; Kocatürk E
Int Arch Allergy Immunol; 2024 Jun; ():1-11. PubMed ID: 38889696
[TBL] [Abstract][Full Text] [Related]
15. Chronic urticaria in the real-life clinical practice setting in the UK: results from the noninterventional multicentre AWARE study.
Savic S; Leeman L; El-Shanawany T; Ellis R; Gach JE; Marinho S; Wahie S; Sargur R; Bewley AP; Nakonechna A; Randall R; Fragkas N; Somenzi O; Marsland A
Clin Exp Dermatol; 2020 Dec; 45(8):1003-1010. PubMed ID: 32246853
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, Management, and Anaphylaxis Risk of Cold Urticaria: A Systematic Review and Meta-Analysis.
Prosty C; Gabrielli S; Le M; Ensina LF; Zhang X; Netchiporouk E; Ben-Shoshan M
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):586-596.e4. PubMed ID: 34673287
[TBL] [Abstract][Full Text] [Related]
17. Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.
He L; Yi W; Huang X; Long H; Lu Q
Clin Rev Allergy Immunol; 2021 Dec; 61(3):424-448. PubMed ID: 34529248
[TBL] [Abstract][Full Text] [Related]
18. Clinical and etiologic evaluation of the children with chronic urticaria.
Azkur D; Civelek E; Toyran M; Mısırlıoğlu ED; Erkoçoğlu M; Kaya A; Vezir E; Giniş T; Akan A; Kocabaş CN
Allergy Asthma Proc; 2016 Nov; 37(6):450-457. PubMed ID: 27931300
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab in chronic spontaneous and inducible urticaria: a 9 year retrospective study in Portugal.
Marcelino J; Costa AC; Mendes A; Alonso E; Cabral Duarte F; Pedro E; Pereira-Barbosa M
Eur Ann Allergy Clin Immunol; 2018 Jul; 50(4):169-176. PubMed ID: 29479938
[No Abstract] [Full Text] [Related]
20. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
Metz M; Ohanyan T; Church MK; Maurer M
J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
